Business World: Takeda's Ramelteon (TAK-375)
Takeda may extend sleeping pill's use for Alzheimer's[ ... Read the full report ...]
Mon Jul 11, 2005 05:41 AM ET
TOKYO, July 11 (Reuters) - Japan's biggest drug maker, Takeda Pharmaceutical Co. Ltd ... said on Monday it is on track to release a sleeping pill as early as September in the United States and may extend its use to treat Alzheimer's disease and other illnesses.
The Osaka-based drug maker plans to launch its insomnia drug Ramelteon in the U.S. market in September or October, marking its entry into the central nervous system disease segment, Takeda President Yasuchika Hasegawa told an analysts' meeting.
Anthony H. Risser | neuroscience | neuropsychology | brain